Acro Biomedical (ACBM) Income from Continuing Operations (2016 - 2025)
Acro Biomedical's quarterly Income from Continuing Operations came in at 42526.0 in Q4 2025, up 498.44% year-on-year from 7106.09 in Q4 2024, and up 136.1% quarter-over-quarter from 117809.0 in Q3 2025.
Acro Biomedical has reported Income from Continuing Operations for 10 years, with the latest figure at 42526.0 in Q4 2025.
- For the quarter ending Q4 2025, Income from Continuing Operations rose 498.44% year-over-year to 42526.0; the trailing twelve-month figure through Dec 2025 stood at 101146.0 (down 139.13% YoY), and the FY2025 full-year result was 101146.0, down 139.13% from the prior year.
- Income from Continuing Operations for Q4 2025 stood at 42526.0, up from 117809.0 in the prior quarter.
- The five-year high for Income from Continuing Operations was 42526.0 in Q4 2025, with the low at 4011322.0 in Q3 2022.
- Average Income from Continuing Operations over 5 years is 1625846.5, with a median of 456248.0 recorded in 2021.
- Year-over-year, Income from Continuing Operations tumbled 6503.69% in 2022 and surged 498.44% in 2025.
- Tracing ACBM's Income from Continuing Operations over 5 years: stood at 3849456.0 in 2021, then dropped by 2.21% to 3934681.0 in 2022, then soared by 99.54% to 18240.0 in 2023, then surged by 41.49% to 10673.0 in 2024, then surged by 498.44% to 42526.0 in 2025.
- The last three Income from Continuing Operations figures came in at 42526.0 (Q4 2025), 117809.0 (Q3 2025), and 15562.0 (Q2 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | EQV Ventures Acquisition | 477.69 Mn | 477.69 Mn | - | 3.87 Mn |
| 2 | Berto Acquisition | 316.66 Mn | 316.66 Mn | - | 2.22 Mn |
| 3 | Centurion Acquisition | 311.94 Mn | 311.94 Mn | - | 2.52 Mn |
| 4 | Churchill Capital Corp IX | 311.36 Mn | 311.36 Mn | - | 1.49 Mn |
| 5 | Agriculture & Natural Solutions Acquisition | 301.94 Mn | 301.94 Mn | - | -612,993.00 |
| 6 | Siddhi Acquisition Corp (Cayman Islands) | 286.76 Mn | 286.76 Mn | - | 2.24 Mn |
| 7 | Bold Eagle Acquisition | 276.06 Mn | 276.06 Mn | - | 2.17 Mn |
| 8 | Cartesian Growth Corp III | 270.68 Mn | 270.68 Mn | - | 1.68 Mn |
| 9 | Oyster Enterprises II Acquisition | 266.84 Mn | 266.84 Mn | - | 2.09 Mn |
| 10 | Acro Biomedical | - | - | - | 42,526.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 42,526.00 |
| Sep 30, 2025 | -117,809.00 |
| Jun 30, 2025 | -15,562.00 |
| Mar 31, 2025 | -10,301.00 |
| Dec 31, 2024 | -10,673.00 |
| Sep 30, 2024 | -10,229.00 |
| Jun 30, 2024 | -10,143.00 |
| Mar 31, 2024 | -11,252.00 |
| Dec 31, 2023 | -18,240.00 |
| Sep 30, 2023 | -1.59 Mn |
| Jun 30, 2023 | -3.20 Mn |
| Mar 31, 2023 | -4.00 Mn |
| Dec 31, 2022 | -3.93 Mn |
| Sep 30, 2022 | -4.01 Mn |
| Jun 30, 2022 | -4.00 Mn |
| Mar 31, 2022 | -3.93 Mn |
| Dec 31, 2021 | -3.85 Mn |
| Sep 30, 2021 | -2.99 Mn |
| Jun 30, 2021 | -794,687.00 |
| Mar 31, 2021 | -59,494.00 |
| Sep 30, 2020 | -73,099.00 |
| Jun 30, 2020 | -63,699.00 |
| Mar 31, 2020 | 81,116.00 |
| Dec 31, 2019 | -75,873.00 |
| Sep 30, 2019 | -75,157.00 |
| Jun 30, 2019 | -50,824.00 |
| Mar 31, 2019 | -169,750.00 |
| Dec 31, 2018 | -75,016.00 |
| Sep 30, 2018 | 153,672.00 |
| Jun 30, 2018 | 116,309.00 |
| Mar 31, 2018 | 69,452.00 |
| Dec 31, 2017 | 80,227.00 |
| Sep 30, 2017 | 39,495.00 |
| Jun 30, 2017 | -11,887.00 |
| Mar 31, 2017 | -22,443.00 |
| Dec 31, 2016 | -7,413.00 |